CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
We have now added a new section called the "Assay History List" to the "At A Gla...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...